image
UroGen Pharma Ltd. URGN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 11.19
-5.65 %
$ 472 M
Market Cap
-3.79
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 28.52% 6.34% 17.09%
Annual Report FY 10-K 2022-12-31 33.96% 1.50% 14.36%
Annual Report FY 10-K 2021-12-31 307.17% 13.75% 27.18%
Annual Report FY 10-K 2020-12-31 65450.00% -27.81% -15.77%
Annual Report FY 10-K 2019-12-31 -98.40% -32.88% -41.85%
Annual Report FY 10-K 2018-12-31 -86.17% -278.28% -286.87%
Annual Report FY 10-K 2017-12-31 -53.46% -930.40% -2500.00%
Annual Report FY 10-K 2016-12-31 0.00% 84.70% 106.43%
Annual Report FY 10-K 2015-12-31 0.00% -178.45% -184.05%
Annual Report FY 10-K 2014-12-31 0.00% -37.84% -28.92%
Annual Report FY 10-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 20.87% -8.20% -29.96%
Quarterly Report Q2 8-K 2024-06-30 3.35% -38.39% -67.98%
Quarterly Report Q1 8-K 2024-03-31 9.24% -6.86% -16.76%
Quarterly Report Q4 8-K 2023-12-31 30.06% 7.90% 27.97%
Quarterly Report Q3 8-K 2023-09-30 29.54% 15.30% 25.36%
Quarterly Report Q2 8-K 2023-06-30 27.31% 9.57% 17.81%
Quarterly Report Q1 8-K 2023-03-31 26.75% -6.41% -0.40%
Quarterly Report Q4 8-K 2022-12-31 11.86% 0.71% -1.84%
Quarterly Report Q3 8-K 2022-09-30 41.81% 14.50% 22.84%
Quarterly Report Q2 8-K 2022-06-30 27.41% -1.79% 18.00%
Quarterly Report Q1 8-K 2022-03-31 81.22% -9.47% 15.92%
Quarterly Report Q4 8-K 2021-12-31 103.04% 6.79% 26.93%
Quarterly Report Q3 8-K 2021-09-30 227.97% -4.84% 19.52%
Quarterly Report Q2 8-K 2021-06-30 3403.23% 16.35% 28.23%
Quarterly Report Q1 8-K 2021-03-31 0.00% 31.38% 32.28%
Quarterly Report Q4 8-K 2020-12-31 0.00% 21.67% 31.59%
Quarterly Report Q3 8-K 2020-09-30 0.00% -29.50% -24.18%
Quarterly Report Q2 8-K 2020-06-30 1966.67% -39.47% -33.88%
Quarterly Report Q1 8-K 2020-03-31 0.00% -76.24% -71.89%
Quarterly Report Q4 8-K 2019-12-31 0.00% -64.33% -65.88%
Quarterly Report Q3 8-K 2019-09-30 0.00% -8.37% -11.21%
Quarterly Report Q2 8-K 2019-06-30 -95.05% -24.69% -28.85%
Quarterly Report Q1 8-K 2019-03-31 0.00% -60.25% -64.46%
Quarterly Report Q4 8-K 2018-12-31 0.00% -135.59% -136.43%
Quarterly Report Q3 8-K 2018-09-30 -96.38% -6790.27% -6860.07%
Quarterly Report Q2 8-K 2018-06-30 0.00% -190.79% -209.76%
Quarterly Report Q1 8-K 2018-03-31 2431.58% -291.63% -285.53%
Quarterly Report Q4 8-K 2017-12-31 -98.13% -81.84% -73.07%
Quarterly Report Q3 8-K 2017-09-30 0.00% 96.27% 95.04%
Quarterly Report Q2 8-K 2017-06-30 0.00% -86.89% -75.29%
Quarterly Report Q1 8-K 2017-03-31 0.00% 17.90% 1.67%
Quarterly Report Q4 8-K 2016-12-31 0.00% 265.56% 299.64%
Quarterly Report Q3 8-K 2016-09-30 0.00% -272.35% -200.39%
Quarterly Report Q2 8-K 2016-06-30 0.00% -158.74% -184.10%
Quarterly Report Q1 8-K 2016-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2015-12-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%